APPL1 and postmenopausal osteoporosis: Because the elderly osteoporosis model has a long construction period, an assessment of treatment efficacy is difficult; therefore, a murine postmenopausal osteoporosis model was used in our studies to examine the effect of APPL1 on osteoporosis.